Loading data for MGRX — first visit, this takes a few seconds.
Mangoceuticals, Inc. (MGRX)
NasdaqCM: MGRX
· Real-Time Price · USD
0.38
-0.01 (-2.56%)
At close: Sep 03, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
Mangoceuticals, Inc. (MGRX) Stock Price, Analysis & Data
No data available
| Bid | 0.28 |
| Market Cap | 8.42M |
| Revenue (ttm) | 315K |
| Net Income (ttm) | -16.6M |
| 0.00 | |
| -1 | |
| n/a | |
| n/a | |
| P/B (ttm) | 0.56 |
| P/S (ttm) | 26.70 |
| Earnings Date | n/a |
| Ask | 0.5 |
| Volume | 187,875 |
| Avg. Volume (20D) | 13,562,995 |
| Open | 0.38 |
| Previous Close | 0.39 |
| Day's Range | 0.37 - 0.40 |
| 52-Week Range | 0.16 - 2.75 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About MGRX
Mangoceuticals, Inc. engages in the development, marketing, and sale of various men's wellness products and services through a telemedicine platform in the United States. The company offers erectile dysfunction products under the Mango brand; hair loss products under the Grow brand; hormone balance and therapy products under the Mojo brand; and weight loss products under the Slim brand. It also provides oral testosterone undecanoate to treat low ...
Industry Health Information Services
Sector Healthcare
IPO Date Mar 21, 2023
Employees 3
Stock Exchange NasdaqCM
Ticker Symbol MGRX
Website https://www.mangoceuticals.com
Financial Performance
In 2025, Mangoceuticals's revenue was 456.02K, a decrease of -25.96% compared to the previous year's 615.87K. Earnings were -20.64M, an increase of 137.11%.
Financial StatementsEarnings Surprise
Mangoceuticals has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
